CD274 and cancer: Programmed death ligand-1 (PD-L1), also known as CD274, contributed to immune evasion and facilitated cancer progression by binding to the programmed death protein-1 (PD-1) in the membrane surface of immune cells, resulting in the dysfunctions of T lymphocytes [24].